Peculate
发表于 2025-3-25 03:44:32
http://reply.papertrans.cn/47/4646/464538/464538_21.png
conjunctivitis
发表于 2025-3-25 09:57:23
Introduction,and that humanity would soon no longer be afflicted by the microbes and viruses which had plagued humanity hitherto. The most notable of these comments came in 1962, when the noted virologist Sir McFarland Burnett stated that “y the end of the Second World War it was possible to say that almost a
花束
发表于 2025-3-25 13:35:50
Applying Lessons from the Past in Haiti: Cholera, Scientific Knowledge, and the Longest-Standing Prle and sickened over 800,000—has propelled a range of complex international law issues into the public eye. The repercussions of the ongoing debate over accountability, and the purposes and limits of UN immunity, are likely to reverberate for years to come. Despite considerable attention from the in
小步走路
发表于 2025-3-25 16:29:39
http://reply.papertrans.cn/47/4646/464538/464538_24.png
Flustered
发表于 2025-3-25 21:38:41
The International Red Cross and Red Crescent Movement Response to the West African Ebola Outbreak 2unified code for infectious disease control. The IHR name the International Federation of the Red Cross (IFRC) as one of the international organisations with whom the WHO must cooperate and co-ordinate in implementing the IHR. It was organisations like the IFRC and MSF, that worked to stop the sprea
Leaven
发表于 2025-3-26 03:03:23
http://reply.papertrans.cn/47/4646/464538/464538_26.png
单调女
发表于 2025-3-26 04:20:42
,Rules and Tools in the Battle Against Superbugs—A Call for Integrated Strategies and Enhanced Interequences of that vulnerability. But even where therapies against infectious diseases had been available, an additional threat has gained world-wide attention: antimicrobial resistance (AMR). A growing number of microbial organisms are becoming resistant to available drugs with increasingly diverse r
exquisite
发表于 2025-3-26 09:05:29
R&D for Emerging Infectious Diseases of Epidemic Potential: Sharing Risks and Benefits Through a Net to human life and prosperity. Research and development (R&D) for new vaccines for EIDs faces two major challenges. The first is R&D preparedness: that is, to advance EID vaccine candidates to the latest R&D stage possible during non-epidemic times, on the basis of any feasible safety or efficacy d
治愈
发表于 2025-3-26 15:05:00
,Restricting Access to Pathogen Samples and Epidemiological Data: A Not-So-Brief History of “Viral S those samples with the World Health Organisation. Indonesia’s sovereignty claims conflicted with the decades-long practice of sharing influenza samples with the WHO, and was seen as an affront to scientific norms of cooperation and openness. The conflict was ostensibly resolved in 2011 with the int
Femine
发表于 2025-3-26 17:00:17
Dual-Use and Infectious Disease Research,nty-first century, the life sciences—including microbiology, virology, and immunology—have been marshalled as key tools in the fight against infectious disease, and the promotion of global health. Rapid advance in these fields, however, has given rise to the “dual-use dilemma,” when one and the same